News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

New drugs show promise in brain tumors

Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)


Posted on: 11/27/2003

New drugs show promise in brain tumors

Reported by Susan Aldridge, PhD, medical journalist

Experiments in mice reveal that four new drugs are effective at combating brain tumors. The survival rate for glioblastoma, the most common and lethal kind of brain tumor, has not changed in ten years and stands at about one year after diagnosis. But researchers at Duke Comprehensive Cancer Center in the US have a promising new approach to brain tumors.

They have tested four new drugs in mice with brain tumors. These drugs are far more precise than existing chemotherapy. They target growth factors within the cancer cells and so stop the tumor from expanding. One drug, which blocks off the blood supply to a tumor, was successful against three different types of brain tumor. This is a remarkable result, given that tumors can be very different in their biological make up.

The researchers also found a combination of two of these drugs to be especially effective. This reflects the increasing trend in cancer treatment towards combination therapy. They hope that this particular combination will be ready for human clinical trials within the next year.


Molecular Targets and Cancer Therapeutics Meeting 20th November 2003

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557